{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:14Z","timestamp":1791356054359,"version":"4.3.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.clindermatol.2007.10.026","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T09:02:09Z","timestamp":1219827729000},"page":"448-459","source":"Crossref","is-referenced-by-count":106,"title":["Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas"],"prefix":"10.1016","volume":"26","author":[{"given":"Gottfried","family":"Wozel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2007.10.026_bib1","series-title":"Dermatologic clinics\u2014psoriasis","first-page":"371","article-title":"From laboratory to clinic: rationale for biologic therapy","author":"Mehlis","year":"2004"},{"issue":"suppl.","key":"10.1016\/j.clindermatol.2007.10.026_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06070.x","article-title":"Biological therapies in the systemic management of psoriasis","volume":"151","author":"Sterry","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib4","series-title":"Textbook of psoriasis","first-page":"3","article-title":"Clinical features","author":"van de Kerkhof","year":"2003"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200102030-00005","article-title":"Psoriasis of the scalp\u2014diagnosis and management","volume":"2","author":"van de Kerkhof","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib6","first-page":"396","article-title":"Natural history and treatment of scalp psoriasis","volume":"49","author":"Farber","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib7","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2165\/00003495-200161110-00006","article-title":"Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment","volume":"61","author":"van der Vleuten","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2340\/0001555572141142","article-title":"The hair root patient in psoriasis of the scalp","volume":"72","author":"Schoorl","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"suppl.","key":"10.1016\/j.clindermatol.2007.10.026_bib9","first-page":"72","article-title":"Microbial associations of 167 patients with psoriasis","volume":"69","author":"Rosenberg","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib10","first-page":"305","article-title":"Microorganisms and psoriasis","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000018026","article-title":"Scalp psoriasis, clinical presentations and therapeutic management","volume":"197","author":"van de Kerkhof","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archderm.138.6.803","article-title":"Scalpdex. A quality-of-life instrument for scalp dermatitis","volume":"138","author":"Chen","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib13","unstructured":"van de Kerkhof PCM, Salonen S-H, on behalf of the EUROPSO Patient Survey Study Group. Large-scale European survey of quality of life in patients with psoriasis: second phase results on quality of life and treatment reported by 7,525 members of European psoriasis patient associations. Published by the European Federation of Psoriasis Foundations (EUROPSO), Helsinki, Finland. Available from: http:\/\/www.europso.org\/ [Sept. 2006]."},{"issue":"suppl. 1","key":"10.1016\/j.clindermatol.2007.10.026_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2005.04.031","article-title":"A clinician's paradigm in the treatment of psoriasis","volume":"53","author":"Lebwohl","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"suppl.","key":"10.1016\/j.clindermatol.2007.10.026_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/ard.2004.032276","article-title":"Psoriasis treatment: current and emerging directed therapies","volume":"64","author":"Winterfield","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1396-0296.2004.04044.x","article-title":"Infliximab","volume":"17","author":"Winterfield","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib17","series-title":"Skin barrier\u2014principles of percutaneous absorption","first-page":"153","author":"Schaefer","year":"1996"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib18","series-title":"Therapy of moderate-to-severe psoriasis","first-page":"29","article-title":"Topical agents in the treatment of moderate-to-severe psoriasis","author":"Callis","year":"2003"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib19","article-title":"Scalp psoriasis\u2014new treatment options are needed","author":"Papp","year":"2006"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.2000.04713.x","article-title":"Topical preparations for the treatment of psoriasis: a systematic review","volume":"146","author":"Mason","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0149-2918(98)80091-X","article-title":"Mometasone furoate 0.1%\u2013salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicentre study","volume":"20","author":"Koo","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib22","first-page":"113","article-title":"\u00dcber Cignolin, ein Ersatzpr\u00e4parat des Chrysarobins","volume":"62","author":"Galewski","year":"1916","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1610-0387.2003.03029.x","article-title":"Dithranol in the treatment of scalp psoriasis","volume":"1","author":"Haas","year":"2003","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib24","series-title":"The benefit\/risk ratio: a handbook for the rational use of potentially hazardous drugs","first-page":"359","article-title":"Topical glucocorticoids with improved benefit\/risk ratio","author":"Sch\u00e4fer-Korting","year":"1999"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.121.1.63","article-title":"Correlation of the vasoconstriction assay and clinical activity in psoriasis","volume":"121","author":"Cornell","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib26","series-title":"Dermatika\u2014Therapeutischer Einsatz, Pharmakologie und Pharmazie","first-page":"76","author":"Niedner","year":"1992"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000081680","article-title":"Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases","volume":"18","author":"Roeder","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00105-006-1182-z","article-title":"Is the psoriasis plaque test still relevant in the age of biologicals?","volume":"57","author":"Wozel","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000069029","article-title":"The topical treatment of psoriasis","volume":"16","author":"van de Kerkhof","year":"2003","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09546630410023566","article-title":"Fluocinolone acetonide topical oil or scalp psoriasis","volume":"15","author":"Pauporte","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(91)70069-E","article-title":"A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis","volume":"24","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-4362.1999.00782.x","article-title":"Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy","volume":"38","author":"Franz","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00128071-200102020-00005","article-title":"Clobetasol propionate foam, 0.05%","volume":"2","author":"Melian","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2133.2003.04950.x","article-title":"Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients","volume":"148","author":"Andreassi","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10227-002-0114-5","article-title":"The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions","volume":"7","author":"Gottlieb","year":"2003","journal-title":"J Cutan Med Surg"},{"issue":"suppl.","key":"10.1016\/j.clindermatol.2007.10.026_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2005.04.029","article-title":"Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis","volume":"53","author":"Stein","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/jid.1967.29","article-title":"Regional variation in percutaneous penetration of 14C cortisol in man","volume":"48","author":"Feldmann","year":"1967","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1986.tb06236.x","article-title":"An open study of vitamin D3 treatment in psoriasis vulgaris","volume":"115","author":"Morimoto","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568010043343930","article-title":"New vitamin D analogs in psoriasis","volume":"3","author":"Fogh","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1468-3083.2005.01198.x","article-title":"Recommendations for the topical treatment of psoriasis","volume":"19","author":"van de Kerkhof","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0773.1995.tb01020.x","article-title":"Calcipotriol: a new drug for topical psoriasis treatment","volume":"77","author":"Kragballe","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128071-200102020-00008","article-title":"Calcipotriol ointment: a review of its use in the management of psoriasis","volume":"2","author":"Scott","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib43","article-title":"Workshop on topical treatment options in psoriasis vulgaris","year":"2003"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000051731","article-title":"Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients","volume":"203","author":"Thaci","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib45","first-page":"65","article-title":"Scalp psoriasis: topical calcipotriol 50 micrograms\/g\/ml solution vs. betamethasone valerate 1% lotion","volume":"20","author":"Duweb","year":"2000","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1994.tb03382.x","article-title":"Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC 903) in the treatment of psoriasis of the scalp","volume":"130","author":"Green","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib47","first-page":"199","article-title":"Long-term treatment of psoriasis with calcipotriol scalp solution and cream","volume":"10","author":"Barnes","year":"2000","journal-title":"Eur J Dermatol"},{"issue":"suppl. 2","key":"10.1016\/j.clindermatol.2007.10.026_bib48","first-page":"175","article-title":"Calcipotriol plus betamethasone dipropionate gel (LEO80185) is effective and safe in the treatment of scalp psoriasis (a phase II study)","volume":"19","author":"Buckley","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib49","first-page":"174","article-title":"Nail psoriasis","volume":"50","author":"Farber","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0733-8635(05)70145-5","article-title":"Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis","volume":"18","author":"van Laborde","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2230.2000.00663.x","article-title":"Management of nail psoriasis","volume":"25","author":"de Berker","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib56","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D31T20Z9WW","article-title":"Topical calcipotriol therapy in nail psoriasis: a study of 24 cases","volume":"11","author":"Zakeri","year":"2005","journal-title":"Dermatol J Onlin"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration\u2013enhancing vehicle: a double-blind study","volume":"199","author":"deJong","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.110.5.735","article-title":"Topically applied fluorouracil in the treatment of psoriatic nails","volume":"110","author":"Frederiksson","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib61","first-page":"27","article-title":"Topical 5-fluourouracil treatment for psoriatic trachyonychia","volume":"62","author":"Schissel","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study","volume":"206","author":"Cannavo","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10227-004-0114-8","article-title":"Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol","volume":"8","author":"Feliciani","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.1998.tb02386.x","article-title":"Topical anthralin therapy for refractory nail psoriasis","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.1993.tb03350.x","article-title":"Response of nail psoriasis to cyclosporin","volume":"129","author":"Arnold","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09546639009086719","article-title":"Retinoids and the nails","volume":"1","author":"Baran","year":"1990","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib68","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib69","first-page":"339","article-title":"Alefacept in the treatment of psoriatic nail disease: a proof of concept study","volume":"5","author":"Parrish","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"suppl. 3","key":"10.1016\/j.clindermatol.2007.10.026_bib70","first-page":"184","article-title":"Etanercept improves nail psoriasis","volume":"52","author":"Rich","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"suppl. 3","key":"10.1016\/j.clindermatol.2007.10.026_bib71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaad.2003.10.504","article-title":"Improvement in nail psoriasis with alefacept","volume":"50","author":"Sobera","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00015550310007463","article-title":"Microorganisms in intertriginous psoriasis: no evidence of Candida","volume":"83","author":"Flytstroem","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib73","first-page":"3","article-title":"Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation","volume":"15","author":"Vissers","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000210775","article-title":"Skin occlusion: treatment or drug-like device?","volume":"1","author":"Barardesca","year":"1988","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib75","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2004-814297","article-title":"Treatment of intertriginous and genito-anal psoriasis","volume":"29","author":"Thaci","year":"2003","journal-title":"Akt Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2001.110046","article-title":"Limited application of fluticasone propionate ointment, 0,005% in patients with psoriasis of the face and intertriginous areas","volume":"44","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib77","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archderm.142.9.1138","article-title":"1% Pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study","volume":"142","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib78","first-page":"127","article-title":"Calcipotriol cream in the treatment of flexural psoriasis","volume":"25","author":"Duweb","year":"2003","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib79","first-page":"764","article-title":"Calcipotriol in the treatment of intertriginous psoriasis","volume":"70","author":"Kienbaum","year":"1995","journal-title":"Zeitschr Hautkr"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib80","first-page":"345","article-title":"Cream based calcipotriol for the treatment of inverse psoriasis and seborrheic dermatitis","volume":"22","author":"Schlehaider","year":"1996","journal-title":"Akt Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib81","first-page":"341","article-title":"Psoriasis in infancy. Therapy with calcipotriene ointment","volume":"68","author":"Travis","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib82","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","article-title":"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 \u03bcg g\u22121 ointment and calcipotriol 50 \u03bcg g\u22121 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas","volume":"148","author":"Ortonne","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2133.1996.tb03851.x","article-title":"Topical calcipotriol in the treatment of intertriginous psoriasis","volume":"135","author":"Kienbaum","year":"1996","journal-title":"Br J Dermatol"},{"issue":"suppl.","key":"10.1016\/j.clindermatol.2007.10.026_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/09546639609080598","article-title":"Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis","volume":"7","author":"Langner","year":"1996","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib85","first-page":"176","article-title":"Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study","volume":"15","author":"Gang","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib86","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial","volume":"111","author":"Reitamo","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib87","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1067\/mjd.2003.169","article-title":"Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas","volume":"48","author":"Freeman","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib88","first-page":"p33","article-title":"The efficacy of 0,1% tacrolimus ointment compared with clobetasonebutyrate 0,05% ointment in patients with facial, flexural or genital psoriasis","volume":"153","author":"Kleyn","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib89","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib90","first-page":"334","article-title":"Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques","volume":"5","author":"Martin Ezquerra","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib91","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2005.05.036","article-title":"Topical tacrolimus in the treatment of inverse psoriasis in children","volume":"53","author":"Steele","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib92","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00105-006-1185-9","article-title":"Calcineurin inhibitors for topical therapy in psoriasis","volume":"57","author":"Wohlrab","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2007.10.026_bib93","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:54:29Z","timestamp":1738346069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X07002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0738081X07002490"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2007.10.026","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}